Revelation Biosciences, Inc. (REVB)
NASDAQ: REVB · Real-Time Price · USD
1.470
+0.010 (0.68%)
At close: Oct 8, 2025, 4:00 PM EDT
1.470
0.00 (0.00%)
After-hours: Oct 8, 2025, 7:52 PM EDT

Revelation Biosciences Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Oct '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
34346693
Market Cap Growth
147.81%22.18%-29.38%-93.27%-28.84%-
Enterprise Value
-2-3-11-270-
Last Close Price
1.4722.13721.019581.07514081.81506521.78
PB Ratio
0.590.820.474.24-666.7027.32
P/TBV Ratio
0.900.820.474.24-30.99
Debt / Equity Ratio
-----0.17-
Quick Ratio
3.303.402.151.180.603.72
Current Ratio
3.423.432.181.220.893.82
Return on Equity (ROE)
-340.81%-264.85%-3.12%-2272.77%-723.81%-
Return on Assets (ROA)
-57.37%-52.93%-61.08%-179.98%-224.21%-
Return on Capital (ROIC)
-204.05%-87.78%-140.53%-1400.45%-448.74%-
Earnings Yield
-338.62%-390.38%-3.81%-242.55%-18.07%-4.07%
FCF Yield
-515.25%-476.09%-231.09%-251.29%-16.92%-2.29%
Updated Aug 8, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q